These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20367204)

  • 21. Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments.
    Kesari S
    Semin Oncol; 2011 Dec; 38 Suppl 4():S2-10. PubMed ID: 22078644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is older age associated with a worse prognosis due to different patterns of care? A long-term study of 1346 patients with glioblastomas or brain metastases.
    Lutterbach J; Bartelt S; Momm F; Becker G; Frommhold H; Ostertag C
    Cancer; 2005 Mar; 103(6):1234-44. PubMed ID: 15666327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetically heterogeneous glioblastoma recurring with disappearance of 1p/19q losses: case report.
    Ito M; Wakabayashi T; Natsume A; Hatano H; Fujii M; Yoshida J
    Neurosurgery; 2007 Jul; 61(1):E168-9; discussion E169. PubMed ID: 17621007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of the treatment and survival rates of 138 patients with glioblastoma multiforme.
    Jubelirer SJ
    W V Med J; 1996; 92(4):186-90. PubMed ID: 8772403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biology and treatment of malignant glioma.
    Prados MD; Levin V
    Semin Oncol; 2000 Jun; 27(3 Suppl 6):1-10. PubMed ID: 10866344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Progress in the study of brain tumor stem cells as treatment targets].
    Hide T; Kuratsu J
    Brain Nerve; 2009 Jul; 61(7):781-9. PubMed ID: 19618855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
    Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
    Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The infrequent simultaneous genetic alterations in glioblastoma multiforme (LOH 10, 17, 19q, TP53 mutation and EGFR amplification) with short clinical course.
    Jesionek-Kupnicka D; Kulczycka D; Rieske P; Szybka M; Jabłońska J; Potemski P; Kolasa P; Liberski PP; Kordek R
    Pol J Pathol; 2007; 58(2):79-85. PubMed ID: 17715673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New therapeutic options in therapy of glioblastoma multiforme].
    Lakomý R; Burkon P; Burkonová D; Jancálek R
    Klin Onkol; 2010; 23(6):381-7. PubMed ID: 21351415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Surgical treatment and radiation therapy for glioblastoma multiforme, with special reference to intraoperative radiotherapy].
    Matsutani M; Matsuda T; Nagashima T; Kohno T; Hoshino T; Terao H
    Gan No Rinsho; 1984 Apr; 30(4):325-33. PubMed ID: 6328061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival trends in elderly patients with glioblastoma multiforme: resective surgery, radiation, and chemotherapy.
    Patwardhan RV; Shorter C; Willis BK; Reddy P; Smith D; Caldito GC; Nanda A
    Surg Neurol; 2004 Sep; 62(3):207-13; discussion 214-5. PubMed ID: 15336860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Glioblastoma in the elderly].
    Laigle-Donadey F; Delattre JY
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Mar; 9(1):101-6. PubMed ID: 21586383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The EGFRvIII variant in glioblastoma multiforme.
    Gan HK; Kaye AH; Luwor RB
    J Clin Neurosci; 2009 Jun; 16(6):748-54. PubMed ID: 19324552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multidisciplinary treatment of glioblastoma].
    Barthelemy N; Gennigens C; Scholtes F; Tshibanda L; Otto B; Piret P; Martin D; Jérusalem G; Coucke P
    Rev Med Liege; 2014; 69 Suppl 1():63-8. PubMed ID: 24822308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NovoTTF-100A: a new treatment modality for recurrent glioblastoma.
    Fonkem E; Wong ET
    Expert Rev Neurother; 2012 Aug; 12(8):895-9. PubMed ID: 22708931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel treatment for glioblastoma: integrin inhibition.
    Chamberlain MC; Cloughsey T; Reardon DA; Wen PY
    Expert Rev Neurother; 2012 Apr; 12(4):421-35. PubMed ID: 22449214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of recent data on the optimization of standards of care in newly diagnosed glioblastoma.
    Cloughesy T
    Semin Oncol; 2011 Dec; 38 Suppl 4():S11-20. PubMed ID: 22078643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life and outcomes in glioblastoma management.
    Colen CB; Allcut E
    Neurosurg Clin N Am; 2012 Jul; 23(3):507-13. PubMed ID: 22748662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent glioblastoma: a fresh look at current therapies and emerging novel approaches.
    Gilbert MR
    Semin Oncol; 2011 Dec; 38 Suppl 4():S21-33. PubMed ID: 22078645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.